Advancing The Careers of Dermatologists 1-10 Years in Practice
September 2025

40-GEP Predicts Response to Adjuvant Radiation in Patients with High-Risk Cutaneous Squamous Cell Carcinoma

Sarah Arron, MD, PhD

Watch Webinar

Recent Webinars

August 2025

Hidradenitis Suppurativa Management Pearls

Ahuva Cices, MD
July 2025

Tips and Tricks for Recognizing Penile and Vulvar Genital Dermatoses

Kelly Tyler, MD
June 2025

A Surgical Oncologist's Perspective on GEP Testing for Cutaneous Melanoma

Joseph Guenther, MD, FACS
View All

Clinical Corner Q&A

View All
Nicholas Brownstone, MD
Nicholas Brownstone, MD | Parasitosis
Q

What is Morgellons disease?

Nicholas Brownstone, MD
Nicholas Brownstone, MD | Medical Dermatology
Q

What is Drug Induced Epidermal Necrolysis (DEN)?

Stephanie K. Fabbro, MD
Stephanie K. Fabbro, MD | CTCL
Q

Does dupilumab increase the risk of cutaneous T-cell lymphoma (CTCL)?

Project Lead is Brought to you by Castle Biosciences

Innovation in prognostic and diagnostic tests for dermatologic cancers enabling more accurate treatment plan decisions. Learn More

Professional Development Videos

View All
Practice Life

How to Become and Stay Board Certified

Andrea Murina, MD
Practice Management

Tips for Medical Assistant Training

Brian Abittan, MD
Practice Finances

Navigating Employment Agreements

Jaimie Rodger, DO
View All
Advertisement

Practice Bits Videos

View All
Alopecia Areata

Low Dose Oral Minoxidil in Unique Populations: Part 1

Kristen Lo Sicco, MD
Skin Cancer

Molecular Insights for Ambiguous Lesions: Clinical Utility of MyPath Melanoma

Hadas Skupsky, MD
Alopecia Areata

Low Dose Oral Minoxidil: Alopecia Updates

Kristen Lo Sicco, MD
View All